Community Pharmacy England (CPE) - News updates

MHRA Class 3 Medicines Recall: Fingolimod Glenmark 0.5 mg Hard Capsules (Glenmark Pharmaceuticals Europe Ltd) Drug Alert Number: EL(26)A/02 Date issued: 21 January 2026 Glenmark Pharmaceuticals Europe Limited is recalling one batch after stability testing showed out-of-specification results. The batch is being recalled as a precautionary measure following test results that showed a delay in capsule [...] The post MHRA Class 3 Medicines Recall: Fingolimod Glenmark 0.5 mg Hard Capsules (Glenmark Pharmaceuticals Europe Ltd) appeared first on Community Pharmacy England.

The second 2025/26 national health campaign starts in just over a weeks time (Monday 2nd February 2026). All pharmacies will need to participate in the campaign, using relevant materials to promote the Pharmacy First service to the public. How to meet the requirements of the campaign Pharmacy owners can meet the requirements of the campaign [...] The post Second national health campaign starts soon appeared first on Community Pharmacy England.

MHRA Class 2 Medicines Recall: Paliperidone Mercury Pharma prolonged-release suspension for injection in pre-filled syringes Drug alert number: EL(26)A/01 Date issued: 20 January 2026 Mercury Pharmaceuticals Ltd is recalling remaining stock of paliperidone pre-filled syringes as a precautionary measure due to Good Manufacturing Practice (GMP) deficiencies cited during a recent inspection at the finished product [...] The post MHRA Class 2 Medicines Recall: Paliperidone Mercury Pharma prolonged-release suspension for injection in pre-filled syringes appeared first on Community Pharmacy England.

iNews, Express The Government has added aspirin to its export ban list to protect supplies for UK patients, with media reports highlighting concerns of ‘serious and growing’ shortages from the Independent Pharmacies Association (IPA). Painkiller drugs shortages hit pharmacies | iNews Essential medicines alert as pharmacies warn of ‘serious and growing’ shortages | Express Community [...] The post Painkiller drugs shortages hit pharmacies appeared first on Community Pharmacy England.

Community Pharmacy England will be holding a webinar on Wednesday, 11th February at 7.30pm to help community pharmacy owners complete the Data Security and Protection Toolkit (DSPTK) 2026.  We have worked with the NHS DSPTK team on the new Toolkit requirements and made improvements to this year’s Toolkit. Both our organisations are eager to support pharmacy owners as you work your way through the Toolkit.  During the webinar, representatives from Community Pharmacy England and the NHS DSPTK team will discuss the Toolkit questions, talk [...] The post Register for our Data Security and Protection Toolkit 2026 Workshop appeared first on Community Pharmacy England.

Trade press Recent reports highlight that nine in ten pharmacies have experienced verbal or physical intimidation from patients who were not eligible for COVID-19 vaccinations, according to data from the National Pharmacy Association. Community Pharmacy England’s current sector Opinion Poll includes important questions about patient abuse towards pharmacy staff. Patient aggression, abuse and intimidation are [...] The post Confusion over COVID vaccinations and rising patient abuse put pressure on pharmacies appeared first on Community Pharmacy England.

The Department of Health and Social Care (DHSC) has today (16/01/2026) confirmed the following initial list of price concessions for January 2026: Drug Pack size Price concession Amoxicillin 250mg/5ml oral suspension 100 £1.44 Aspirin 75mg dispersible tablets 28 £2.19 Aspirin 75mg dispersible tablets 100 £7.82 Betamethasone 500microgram soluble tablets sugar free 100 £47.89 Carbocisteine 375mg [...] The post January 2026 Price Concessions 1st Update appeared first on Community Pharmacy England.

Update 16/01/26 – The Department of Health and Social Care (DHSC) has provided an update on the Serious Shortage Protocol (SSP) for Creon® 25000 gastro-resistant capsules (SSP061) was due to expire 16 January 2026 but has been further extended to Friday 17 April 2026. Update 20/11/25 – The Department of Health and Social Care (DHSC) [...] The post SSP61 – Creon® 25000 gastro-resistant capsules further extended appeared first on Community Pharmacy England.

Update 16/01/26 – The Department of Health and Social Care (DHSC) has provided an update on the Serious Shortage Protocol (SSP) for Creon® 25000 gastro-resistant capsules (SSP061) was due to expire 16 January 2026 but has been further extended to Friday 30 January 2026. Update 20/11/25 – The Department of Health and Social Care (DHSC) [...] The post SSP60 – Creon® 10000 gastro-resistant capsules further extended appeared first on Community Pharmacy England.

Department of Health and Social Care (DHSC) has issued a medicine supply notification for Buprenorphine/naloxone (Suboxone®) 2mg/500microgram and 8mg/2mg sublingual tablets. MSN/2026/002 Tier 2 – Medium impact Date of issue: 15 January 2026 Buprenorphine/naloxone (Suboxone®) 2mg/500microgram and 8mg/2mg sublingual tablets were discontinued on 5th January 2026. Various strengths (0.7mg/0.18mg, 1.4mg/0.36mg, 5.7mg/1.4mg, 8.6mg/2.1mg, and 11.4mg/2.9mg) of [...] The post Medicine Supply Notification: Buprenorphine/naloxone (Suboxone® ) 2mg/500microgram and 8mg/2mg sublingual tablets appeared first on Community Pharmacy England.